{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:56:53Z","timestamp":1789408613176,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.coviro.2012.03.007","type":"journal-article","created":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T14:46:35Z","timestamp":1334155595000},"page":"309-314","source":"Crossref","is-referenced-by-count":46,"title":["The role of vaccination in rabies prevention"],"prefix":"10.1016","volume":"2","author":[{"given":"Deborah J","family":"Briggs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2012.03.007_bib0005_1","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1586\/erv.11.140","article-title":"From brain passage to cell adaptation: The road of human rabies vaccine development","volume":"10","author":"Wu","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coviro.2012.03.007_bib0010","unstructured":"Division of Environmental Health: http:\/\/www.doh.wa.gov\/ehp\/ts\/zoo\/about.htm (updated January 2012) cited February 28, 2012."},{"key":"10.1016\/j.coviro.2012.03.007_bib0015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/bmj.1.1468.342","article-title":"On rabies: its treatment by m. Pasteur, and on the means of detecting it in suspected cases","volume":"1","author":"Horsley","year":"1889","journal-title":"Br Med J"},{"key":"10.1016\/j.coviro.2012.03.007_bib0020","series-title":"Rabies","first-page":"1","article-title":"The history of rabies","author":"Baer","year":"2007"},{"key":"10.1016\/j.coviro.2012.03.007_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1353\/pbm.1996.0037","article-title":"Joseph-Alexandre Auzias-Turenne, Louis Pasteur, and early concepts of virulence, attenuation, and vaccination","volume":"39","author":"Burke","year":"1996","journal-title":"Perspect Biol Med"},{"key":"10.1016\/j.coviro.2012.03.007_bib0030","first-page":"491","article-title":"Neurological complications in adults following rabies vaccine prepared from animal brains","volume":"25","author":"Bahri","year":"1996","journal-title":"Presse Med"},{"key":"10.1016\/j.coviro.2012.03.007_bib0035","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1590\/S0034-89101994000600010","article-title":"Treatment of human rabies: a summary of its history","volume":"28","author":"Schneider","year":"1994","journal-title":"Rev Saude Publica"},{"key":"10.1016\/j.coviro.2012.03.007_bib0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1590\/S0037-86822004000100002","article-title":"Adverse reactions associated with a fuenzalida-palacios rabies vaccine: a quasi-experimental study","volume":"37","author":"Bonito","year":"2004","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.coviro.2012.03.007_bib0045","first-page":"1","article-title":"Who expert committee on rabies","volume":"709","year":"1984","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.coviro.2012.03.007_bib0050","first-page":"1","article-title":"Who expert committee on rabies","volume":"824","author":"WHO","year":"1992","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.coviro.2012.03.007_bib0055","first-page":"80","article-title":"Who expert committee on rabies-second report","volume":"71","author":"WHO","year":"1954","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.coviro.2012.03.007_bib0060","first-page":"173","article-title":"Propagation of rabies virus in tissue culture","volume":"23","author":"Wiktor","year":"1966","journal-title":"Monogr Ser World Health Organ"},{"key":"10.1016\/j.coviro.2012.03.007_bib0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4049\/jimmunol.93.3.353","article-title":"Cultivation of rabies virus in human diploid cell strain wi-38","volume":"93","author":"Wiktor","year":"1964","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2012.03.007_bib0070","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jama.1973.03220220072012","article-title":"Human cell culture rabies vaccine. Antibody response in man","volume":"224","author":"Wiktor","year":"1973","journal-title":"JAMA"},{"key":"10.1016\/j.coviro.2012.03.007_bib0075","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1001\/jama.1976.03270250019017","article-title":"Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum","volume":"236","author":"Bahmanyar","year":"1976","journal-title":"JAMA"},{"key":"10.1016\/j.coviro.2012.03.007_bib0080","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(75)91761-4","article-title":"Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers","volume":"1","author":"Aoki","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2012.03.007_bib0085","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1001\/jama.1981.03320200020017","article-title":"Booster effect of human diploid cell antirabies vaccine in previously treated persons","volume":"246","author":"Fayaz","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.coviro.2012.03.007_bib0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0264-410X(86)90096-4","article-title":"Immune complex-like disease in 23 persons following a booster dose of rabies human diploid cell vaccine","volume":"4","author":"Dreesen","year":"1986","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2012.03.007_bib0095","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2460\/javma.1984.184.05.514a","article-title":"Unavailability of human diploid cell rabies vaccine","volume":"184","author":"Dreesen","year":"1984","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.coviro.2012.03.007_bib0100_1","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.coviro.2012.03.007_bib0105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0264-410X(89)90152-7","article-title":"Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization","volume":"7","author":"Dreesen","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2012.03.007_bib0110_1","series-title":"Rabies","article-title":"The immunological basis for immunization series","author":"WHO","year":"2011"},{"key":"10.1016\/j.coviro.2012.03.007_bib0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(86)91946-X","article-title":"New purified vero-cell vaccine prevents rabies in patients bitten by rabid animals","volume":"2","author":"Suntharasamai","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2012.03.007_bib0120","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1128\/CVI.05090-11","article-title":"Persistence of rabies antibody 5 years after postexposure prophylaxis with vero cell antirabies vaccine and antibody response to a single booster dose","volume":"18","author":"Zhang","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coviro.2012.03.007_bib0125","series-title":"WHO Prequalified Vaccines","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.coviro.2012.03.007_bib0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/312163a0","article-title":"Expression of rabies virus glycoprotein from a recombinant vaccinia virus","volume":"312","author":"Kieny","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2012.03.007_bib0135","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1073\/pnas.81.22.7194","article-title":"Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene","volume":"81","author":"Wiktor","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2012.03.007_bib0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/322373a0","article-title":"Oral vaccination of the fox against rabies using a live recombinant vaccinia virus","volume":"322","author":"Blancou","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2012.03.007_bib0145","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1073\/pnas.83.20.7947","article-title":"Oral immunization and protection of raccoons (procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine","volume":"83","author":"Rupprecht","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2012.03.007_bib0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/vr.123.19.481","article-title":"First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus","volume":"123","author":"Pastoret","year":"1988","journal-title":"Vet Rec"},{"key":"10.1016\/j.coviro.2012.03.007_bib0155","doi-asserted-by":"crossref","first-page":"228","DOI":"10.7589\/0090-3558-34.2.228","article-title":"First north american field release of a vaccinia-rabies glycoprotein recombinant virus","volume":"34","author":"Hanlon","year":"1998","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.coviro.2012.03.007_bib0160","first-page":"1","article-title":"Compendium of animal rabies prevention and control","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.coviro.2012.03.007_bib0165","first-page":"241","article-title":"Clinical trial with an anti-rabies human diploid cell vaccine (hdcv)","volume":"41","author":"Gerichter","year":"1978","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.coviro.2012.03.007_bib0170","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0264-410X(97)00207-7","article-title":"Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine","volume":"15","author":"Vodopija","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2012.03.007_bib0175","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0264-410X(88)90098-9","article-title":"Comparative study of two human diploid rabies vaccines administered with antirabies globulin","volume":"6","author":"Vodopija","year":"1988","journal-title":"Vaccine"},{"issue":"Suppl.","key":"10.1016\/j.coviro.2012.03.007_bib0180","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0264-410X(96)00315-5","article-title":"Progress and achievement of rabies control in thailand","author":"Wasi","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2012.03.007_bib0185","first-page":"3","article-title":"Postexposure prophylaxis for rabies with antiserum and intradermal vaccination","volume":"335","author":"Chutivongse","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2012.03.007_bib0190","article-title":"Report of a who consultation on the intradermal application of human rabies vaccines","author":"WHO","year":"1985","journal-title":"Press Release"},{"key":"10.1016\/j.coviro.2012.03.007_bib0195","first-page":"1","article-title":"WHO expert consultation on rabies","volume":"931","year":"2005","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.coviro.2012.03.007_bib0200","series-title":"Rabies, Countries or Areas at Risk","year":"2012"},{"key":"10.1016\/j.coviro.2012.03.007_bib0205_1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/B978-0-12-387040-7.00016-0","article-title":"Design of future rabies biologics and antiviral drugs","volume":"79","author":"Smith","year":"2011","journal-title":"Adv Virus Res"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187962571200051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187962571200051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T19:06:34Z","timestamp":1742929594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187962571200051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S187962571200051X"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2012.03.007","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}